Breaking News

Catalent to be Added to S&P 500 Index

The CDMO will move from the S&P MidCap 400 to the S&P 500 on Sept. 21, 2020.

By: Contract Pharma

Contract Pharma Staff

Catalent, Inc., a global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, said the company is being added to the iconic S&P 500 index published by S&P Dow Jones Indices.   S&P Dow Jones Indices is the largest global resource for essential index-based concepts, data, and research, and home to many well-known financial market indicators, including the Dow Jones Industrial Av...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters